Advertisement
Screener

SCIENTURE HOLDINGS, INC. (SCNX) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

SCIENTURE HOLDINGS, INC. Cash Flow Breakdown

Cash flow breakdown shows where SCIENTURE HOLDINGS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $13.38M went out.
  • Fiscal year ended 2025-12-31: from financing, $19.73M came in.
  • Fiscal year ended 2025-12-31: change in cash, $6.35M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDividendsNew debtCommercial paperNew shares soldNot split outChange in cash
2025-12-31-$13.38M$26.29M-$6.56M*$6.35M
2024-12-31-$14.27M$27.55M-$14.86M$2.95M-$1.07M*$307.78K
2023-12-31-$2.23M-$275.72K$1.41M*-$1.09M
2022-12-31-$1.53M-$427.85K$130.92K-$2.03M
2021-12-31-$2.57M-$22.60K$1.82K-$2.80M
2020-12-31-$2.21M-$37.51K$5.99M-$694.25K*$3.05M
2019-12-31$141.78K-$332.25K$2.46M$2.00M
2018-12-31$273.39K-$265.28K$800.00K$685.64K
2017-12-31$171.67K$0.00$250.00K$169.24K
2016-12-31-$503.53K-$78.00K$300.00K-$64.03K
2015-12-31$90.39K$950.00K$205.00K$0.00-$617.11K
2014-12-31-$1.06M$0.00$0.00$1.20M$621.28K
2013-12-31-$844.58K$10.99K$936.51K*$80.94K

Each quarter (3 month)

Quarter endRunning the businessFrom investingDividendsCommercial paperNew shares soldNot split outChange in cash
2026-06-30-$3.13M*$10.79M*
2026-03-31-$2.92M-$3.12M
2025-12-31-$5.18M*$14.82M*-$3.34M*
2025-09-30-$3.21M*$6.87M*-$3.32M*
2025-06-30-$2.03M*$0.00*
2025-03-31-$2.96M$4.60M$1.74M
2024-12-31-$2.91M*$0.00*$0.00*$0.00*$2.79M*
2024-09-30-$5.39M*$120.98K*-$2.19M*$0.00*
2024-06-30$4.22M*-$774.00*$0.00*$0.00*
2024-03-31-$10.19M$27.43M-$12.67M$9.84K-$1.23M*$3.35M
2023-12-31-$1.02M*-$350.00K*$1.34M*
2023-09-30-$603.11K*-$207.11K*
2023-06-30$328.57K*-$51.80K*-$725.28K*
2023-03-31-$931.53K$333.20K$681.26K*$82.92K
2022-12-31$1.23M*-$114.94K*
2022-09-30-$576.92K*-$55.73K*
2022-06-30-$1.18M*-$280.17K*$550.00K*
2022-03-31-$1.00M$23.00K-$1.25M
2021-12-31-$426.71K*$0.00*
2021-09-30-$738.10K*$0.00*
2021-06-30-$691.12K*
2021-03-31-$710.30K-$710.30K
2020-12-31-$715.53K*-$14.00K*$0.00*
2020-09-30$2.48M*$0.00*$0.00*
2020-06-30-$3.57M*$0.00*$0.00*
2020-03-31-$410.81K-$23.50K$5.99M-$730.50K*$4.83M
2019-12-31-$182.79K*-$82.25K*$0.00*
2019-09-30$404.25K*$0.00*$2.42M*
2019-06-30$46.10K*-$40.00K*
2019-03-31-$125.79K-$210.00K-$335.63K
2018-12-31$42.07K*$500.00K*
2018-09-30$84.86K*$0.00*$300.00K*$384.86K*
2018-06-30$79.79K*-$61.73K*$0.00*$18.07K*
2018-03-31$66.66K-$50.00K$0.00$5.92K
2017-12-31$53.32K*$0.00*$0.00*$10.58K*
2017-09-30$116.78K*$0.00*$0.00*$70.13K*
2017-06-30$49.86K*$0.00*$0.00*-$66.79K*
2017-03-31-$48.28K$0.00$250.00K$155.32K
2016-12-31$1.05M*$0.00*$0.00*-$74.38K*
2016-09-30-$711.53K*$0.00*$150.00K*$61.41K*
2016-06-30-$763.51K*$150.00K*$16.50K*
2016-03-31-$82.04K$0.00-$67.57K
2015-12-31$876.37K*$0.00*$951.67K*-$236.13K*
2015-09-30-$89.55K*$0.00*-$89.55K*
2015-06-30-$326.13K*$78.87K*
2015-03-31-$370.30K-$370.30K
2014-12-31-$365.25K*$800.00K*$434.75K*
2014-09-30-$286.89K*$0.00*$400.00K*$200.36K*
2014-06-30-$163.09K*$0.00*-$39.84K*
2014-03-31-$249.36K$4.25K$26.00K
2013-12-31-$483.05K*$21.97K*$534.60K*$51.54K*
2013-09-30-$243.59K*-$3.26K*$0.00*$20.96K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Dare Bioscience, Inc. (DARE)United States$0.011B
BIOVIE INC. (BIVI)United States$0.012B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Moleculin Biotech, Inc. (MBRX)United States$0.011B
MetaVia Inc. (MTVA)United States$0.011B-0.65
KALA BIO, Inc. (KALA)United States$0.011B-3.33